ZIBO, China, April 29, 2026 /PRNewswire/ -- INTCO Medical ("INTCO" or "the Company"), a leading global manufacturer of disposable gloves, reported its 2025 annual results, with revenue reaching RMB 9.93 billion (approximately US$1.46 billion), up 4.23% year over year and marking a four-year high.
The company's annualized production capacity for disposable non-latex gloves reached 103 billion pieces, including 70 billion nitrile gloves, placing INTCO among the world's largest disposable glove manufacturers by production capacity and a top global nitrile glove manufacturer.
During the reporting period, INTCO maintained stable operations amid industry rebalancing. Net profit attributable to shareholders reached RMB 1.01 billion (approximately US$148.03 million), while total assets exceeded RMB 40 billion (approximately US$5.86 billion), up 15.77% year over year. Gross margin rose 0.48 percentage points to 24.12%, and net cash flow from operating activities increased 74.69% to RMB 1.89 billion (approximately US$277.00 million), supporting the company's global expansion and long-term growth.
Scale and Manufacturing Capabilities Strengthen Core Business
Disposable gloves remained INTCO Medical's core business. As of the end of 2025, the company operated 10 R&D and manufacturing bases worldwide, with annualized capacity for disposable non-latex gloves reaching 103 billion pieces, including 70 billion nitrile gloves and 33 billion vinyl gloves.
The company continued to enhance its automated production systems, self-developed production lines and precision DCS systems to improve production efficiency, energy utilization and product quality. Its production scale remained among the industry's largest, with product yield continuing to stay above 99%.
With a global development strategy, INTCO Medical expanded overseas production capacity, including new facilities in Vietnam, strengthening supply chain resilience, supporting stable delivery and enhancing responsiveness to regional demand.
Beyond its core glove business, INTCO expanded its healthcare and personal protection portfolio, with rehabilitation medical equipment and physical therapy businesses growing and supporting a more balanced revenue mix.
Global Reach, Innovation and Digitalization Support Long-Term Growth
Investment in innovation remained a key strategic priority. In 2025, research and development spending reached RMB 404 million (approximately US$59.21 million), representing 4.07% of revenue and significantly above the industry average, reflecting the company's continued commitment to innovation.
The company continued to advance new materials, automation technologies, and product development, including the launch of innovative products such as Syntex™ Synthetic Disposable Latex Gloves and Synmax Pro Exam Gloves. Total patent holdings continued to grow, strengthening long-term competitive barriers.
INTCO continued to deepen its global market network, serving more than 15,000 customers across more than 150 countries and regions. Supported by a global marketing team of nearly 500 professionals, the company has established marketing and service centers in the U.S., Canada, Germany, Japan, Malaysia, Singapore and Hong Kong SAR, China, with plans to further expand in the Middle East, South America and Oceania to better support local customers.
INTCO is integrating digital technologies and AI across its operations, using data platforms and AI-driven tools to improve efficiency, decision-making and internal capabilities. The company continued to advance its ESG practices, including wind and solar projects that generated 12,537.23 MWh of clean energy in 2025, supporting sustainable development.
Looking ahead, INTCO will leverage its scale, technology and global network to strengthen its healthcare supply chain, improve efficiency, expand overseas capacity and accelerate product innovation.
About INTCO Medical
INTCO Medical is a leading global manufacturer of disposable gloves. As a high-tech manufacturing company, INTCO specializes in the R&D, production and marketing of medical consumables and durable medical equipment. The company's core business segments include medical consumables, rehabilitation medical equipment and physical therapy. For more information, please visit https://www.intcomedical.com/.
** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **
INTCO Medical Reports 2025 Results with Resilient Growth, Revenue Reaches Four-Year High as Industry Rebalances
KUALA LUMPUR, Malaysia, April 29, 2026 /PRNewswire/ -- ARC Group will host the Capital Markets & M&A Forum 2026: Malaysia Edition in Kuala Lumpur, continuing its role in delivering one of Southeast Asia's most established platforms for capital markets dialogue and cross-border collaboration. The forum will take place on May 7, 2026, at EQ, Equatorial Plaza, Kuala Lumpur, bringing together senior executives, investors, advisors, and industry leaders from across regional and global markets.
Building on the success of prior editions, now in its fourth year, the 2026 forum will further strengthen engagement across the financial ecosystem while reinforcing ARC Group's commitment to responsible global engagement and long-term industry collaboration. Speakers will include Hiren Krishnani, Senior Director at Nasdaq, who leads capital markets activities across the ASEAN region and will share insights on navigating global capital markets and positioning companies for successful listings.
Register for the event here.
Sponsors of the Capital Markets & M&A Forum 2026
The Capital Markets & M&A Forum 2026: Malaysia Edition is supported by a distinguished group of sponsors representing leading institutions across capital markets, legal advisory, accounting, and professional services.
ARC Group extends its sincere appreciation to the following sponsors for their continued support and collaboration in advancing cross-border dialogue and strengthening connections across Southeast Asia's financial ecosystem.
Sponsors Include:
- ARC Group Securities
- MarcumAsia
- Sichenzia Ross Ference Carmel （SRFC）
- Hunter Taubman Fischer & Li LLC (HTFL)
- SFAI Malaysia PLT
- UHY
- NS Cell Company Limited
- Rimôn Law
- King Kee Appraisal and Advisory
- Ogier
- KL Wellness City
- Ascentium 皋翊 (FKA Harneys)
- Edgar Agents
- Appleby
- Efficiency
- Federal Filings
- Lucosky Brookman LLP
Their participation reflects a shared commitment to supporting capital formation, facilitating cross-border transactions, and fostering collaboration across regional and global markets.
Supporting Feed My Starving Children
As part of this year's Capital Markets & M&A Forum Kuala Lumpur, ARC Group is proud to support Feed My Starving Children (FMSC), a nonprofit organization dedicated to providing nutritious meals to children and families facing hunger around the world.
Through partnerships with local organizations in more than 70 countries, FMSC distributes life-saving meals to communities most in need, helping address one of the world's most pressing humanitarian challenges.
Attendees, partners, and members of the broader network are invited to support this initiative through voluntary contributions made via the fundraising page linked below.
For perspective, a contribution of just $106 can provide a child with one nutritious meal every day for an entire year, helping deliver sustained nutritional support to communities facing food insecurity.
Support the initiative here.
About the Event
The forum will feature keynote presentations and panel discussions led by senior industry professionals, focusing on key trends shaping capital markets, mergers and acquisitions, and international expansion strategies. Confirmed speakers include Drew Bernstein, Co-CEO of MarcumAsia; Paul Chong, Partner at ARC Group; and Ian Hanna, CEO of ARC Securities.
Additional sessions will explore the intersection of entrepreneurship, capital strategy, and international expansion, highlighting Southeast Asia's growing role as a hub for cross-border investment.
With participation expected to exceed previous years, the 2026 Kuala Lumpur edition aims to be the largest forum to date, reinforcing ARC Group's commitment to supporting Malaysia's financial ecosystem and connecting regional companies with global capital opportunities.
Register for the event here.
About ARC Group
ARC Group is a global investment bank and management consultancy supporting companies through cross-border financial advisory, M&A, IPOs, SPAC transactions, financing, and consulting services. Headquartered in Hong Kong with offices in Mainland China, the United States, Southeast Asia, Europe, and the Middle East, ARC Group delivers integrated solutions across multiple jurisdictions.
For Media Inquiries, Please Contact:
ARC Group
June Xie
june.xie@arc-group.com
** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **
ARC Group Announces Sponsors and Charitable Initiative for Capital Markets & M&A Forum 2026
ARC Group Announces Sponsors and Charitable Initiative for Capital Markets & M&A Forum 2026
